FDA Inspection 1249756 — Axogen Corp
The FDA completed an inspection of Axogen Corp on Sep 6, 2024 in Vandalia, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 6, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Vandalia, OH (United States)